Need help navigating aged care? Explore our support services
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

People with dementia “May make the science of dementia better” says leading dementia expert

Posted
by DPS

Dr Kenneth Rockwood, a leading Canadian geriatrician, says that one of the most powerful tools in the management of dementia is being overlooked by scientists and researchers: people who are living with dementia themselves.

Dr Rockwood is in Australia for Dementia Awareness Month as the guest of Alzheimer’s Australia, the national peak body for people with dementia and their carers, to talk about the challenges that the dementia epidemic is bringing in treating people with dementia.

Dr Rockwood says that while dementia research has made great progress in the last 20 years, there is a long way to go in having the evaluative tools that assist clinicians in assessing the value of different treatments.

In his own research, Dr Rockwood has found that people with dementia were often well placed to evaluate the impact of treatment on their own health and wellbeing.

As a result he suggests that people with dementia should be listened to more widely by clinicians and that their personal experience should be considered when evaluating new dementia treatments.

“Making judgements about the benefits of treatments for individual patients on the basis of, say, a four-point change on a given scale is wrong for clinical decision-making,” argues Dr Rockwood. “Our latest research shows that while batteries of neuro-psychological tests assist in classifying groups of people they do not translate to whether a given treatment is helping a given individual.

“A person’s own insight and experience may well help to improve the level of care and medical treatment that we can offer to people with dementia.”

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo